Assignee
EPSTEIN ALAN L
US·8 granted patents·2 pending applications·83 citations·filing 2004–2016
Top patents by PatentIndex Score
10 records- 0196US8124066B2Methods of using interleukin-2 mutants with reduced toxicityEPSTEIN ALAN L·Filed 2010·Granted Feb 28, 2012·37 cites·12 claims
- 0294US9522958B2Cancer targeted innate immunityEPSTEIN ALAN L·Filed 2011·Granted Dec 20, 2016·34 cites·12 claims
- 0381US8545838B2Compositions and methods for cancer immunotherapyEPSTEIN ALAN L·Filed 2007·Granted Oct 1, 2013·3 cites·46 claims
- 0478US10711064B2Lym-1 and Lym-2 targeted CAR cell immunotherapyEPSTEIN ALAN L·Filed 2016·Granted Jul 14, 2020·1 cites·16 claims
- 0578US10196435B2OX40L fusion protein for the immunotherapy of tumors of veterinary animalsEPSTEIN ALAN L·Filed 2014·Granted Feb 5, 2019·2 cites·8 claims
- 0674US8883497B2Human myeloid derived suppressor cell cancer markersEPSTEIN ALAN L·Filed 2012·Granted Nov 11, 2014·4 cites·8 claims
- 0773US8795672B2Compositions and methods for cancer immunotherapyEPSTEIN ALAN L·Filed 2004·Granted Aug 5, 2014·2 cites·7 claims
- 0862US2014099305A1Compositions and methods for cancer immunotherapyEPSTEIN ALAN L·Filed 2013·Application pending·0 cites
- 0953US9746480B2Human myeloid derived suppressor cell cancer markersEPSTEIN ALAN L·Filed 2014·Granted Aug 29, 2017·0 cites·3 claims
- 1051US2006135459A1Targeted innate immunityEPSTEIN ALAN L·Filed 2005·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →